Skip to main content
. 2006 Dec;3(12):39–49.

Table 4.

Distribution of alprazolam ODT doses at Baseline, Week 4, and Endpoint

Starting Dose ITT N=125 Week 4 Dose ITT N=125 Endpoint Dose ITT N=125 Endpoint Dose Completers N=92
Mean (mg/day)a

  • 1.09

  • 1.01

  • 1.00

  • 0.85
Median (mg/day)a

  • 1.00

  • 1.00

  • 0.75

  • 0.50
Range, n (%)

  • 0mg/day

  • >0–0.25mg/day

  • >0.25–0.50mg/day

  • >0.50–0.75mg/day

  • >0.75–1.00mg/day

  • >1.00–1.50mg/day

  • >1.50–2.00mg/day

  • >2.00–3.00mg/day

  • >3.00–5.00mg/day

  • >5.00mg/day

  • Not Availableb

  • 0

  • 0

  • 45 (36.0%)

  • 1 (0.8%)

  • 27 (21.6%)

  • 42 (33.6%)

  • 1 (0.8%)

  • 4 (3.2%)

  • 1 (0.8%)

  • 0

  • 4 (3.2%)

  • 1 (0.8%)

  • 7 (5.6%)

  • 41 (32.8%)

  • 2 (1.6%)

  • 21 (16.8%)

  • 24 (19.2%)

  • 4 (3.2%)

  • 6 (4.8%)

  • 0

  • 0

  • 19 (15.2%)

  • 71 (56.8%)

  • 4 (3.2%)

  • 19 (15.2%)

  • 0

  • 10 (8.0%)

  • 9 (7.2%)

  • 0

  • 4 (3.2%)

  • 0

  • 0

  • 8 (6.4%)

  • 62 (67.4%)

  • 4 (4.3%)

  • 12 (13.0%)

  • 0

  • 4 (4.3%)

  • 3 (3.3%)

  • 0

  • 2 (2.2%)

  • 0

  • 0

  • 5 (5.4%)
a

Means and medians calculated for subjects receiving any dose >0

b

Subjects for whom a dose was not recorded